Non-Vasculitic Cutaneous Involvement

  • Hobart W. Walling
  • Richard D. Sontheimer


As with other clinically and genetically heterogeneous, multisystem autoimmune disorders, cutaneous abnormalities are frequently encountered in Sjogren’s syndrome (SjS). Thus, it is important to have a rational framework for identifying and treating skin changes that can be encountered in SjS patients and to understand the relationships of key skin changes to the SjS systemic disease process.


Skin Change Alopecia Areata Oral Candidiasis Systemic Amyloidosis Subacute Cutaneous Lupus Erythematosus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



There was no extramural support for this project. Dr. Sontheimer’s effort on this project were facilitated by internal support from the University of Utah Department of Dermatology in return for his work in strengthening the departmental academic mission. We express our appreciation to the following individuals who generously provided clinical images to illustrate this chapter: Jan P. Dutz, M.D. (Department of Dermatology, University of British Columbia, Canada) as well as Glen M. Bowen, M.D. and Scott R. Florell, M.D. (Department of Dermatology, University of Utah School of Medicine, USA).

Conflicts of interest None to declare.

External funding sources None.


  1. 1.
    Flint SR, Watson R, Provost TT. Mucocutaneous manifestatons of Sjogren syndrome. In: Cutaneous manifestations of rheumatic diseases. 2 ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 135–52.Google Scholar
  2. 2.
    Soy M, Piskin S. Cutaneous findings in patients with primary Sjögren’s syndrome. Clin Rheumatol. 2007;26:1350–2.PubMedCrossRefGoogle Scholar
  3. 3.
    Roguedas AM, Misery L, Sassolas B, Le MG, Pennec YL, Youinou P. Cutaneous manifestations of primary Sjögren’s syndrome are underestimated. Clin Exp Rheumatol. 2004;22:632–6.PubMedGoogle Scholar
  4. 4.
    Bernacchi E, Amato L, Parodi A, Cottoni F, Rubegni P, De PO, et al. Sjögren’s syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin Exp Rheumatol. 2004;22:55–62.PubMedGoogle Scholar
  5. 5.
    Connolly MK. Sjogern’s syndrome. Semin Cutan Med Surg. 2001;20:46–52.PubMedCrossRefGoogle Scholar
  6. 6.
    Fox RI, Liu AY. Sjögren’s syndrome in dermatology. Clin Dermatol. 2006;24:393–413.PubMedCrossRefGoogle Scholar
  7. 7.
    Provost TT, Watson R. Cutaneous manifestations of Sjögren’s syndrome. Rheum Dis Clin North Am. 1992;18:609–16.PubMedGoogle Scholar
  8. 8.
    Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren’s syndrome. A clinical, pathological, and serological study of sixty-two cases. 1965. Medicine (Baltimore). 1992 Nov;71(6):386-401; discussion 401-3. PubMed PMID: 1435231Google Scholar
  9. 9.
    Hart LE, Caspi D, Hull RG, Begant A, Beacham J, Hughes GR. Sweat gland function in Sjögren’s syndrome. Ann Rheum Dis. 1986;45:350–1.PubMedCrossRefGoogle Scholar
  10. 10.
    Kovács L, Török T, Bari F, Kéri Z, Kovács A, Makula E, et al. Impaired microvascular response to cholinergic stimuli in primary Sjögren’s syndrome. Ann Rheum Dis. 2000;59:48–53.PubMedCrossRefGoogle Scholar
  11. 11.
    Mandl T, Bornmyr SV, Castenfors J, Jacobsson LT, Manthorpe R, Wollmer P. Sympathetic dysfunction in patients with primary Sjögren’s syndrome. J Rheumatol. 2001;28:296–301.PubMedGoogle Scholar
  12. 12.
    Bernacchi E, Bianchi B, Amato L, Giorgini S, Fabbri P, Tavoni A, et al. Xerosis in primary Sjögren syndrome: immunohistochemical and functional investigations. J Dermatol Sci. 2005;39:53–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Katayama I, Koyano T, Nishioka K. Prevalence of eyelid dermatitis in primary Sjögren’s ­syndrome. Int J Dermatol. 1994;33:421–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol. 2009;10:365–81.PubMedCrossRefGoogle Scholar
  15. 15.
    Katayama I, Kotobuki Y, Kiyohara E, Murota H. Annular erythema associated with Sjögren’s syndrome: review of the literature on the management and clinical analysis of skin lesions. Mod Rheumatol. 2010;20:123–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Lundström IM, Lindström FD. Subjective and clinical oral symptoms in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 1995;13:725–31.PubMedGoogle Scholar
  17. 17.
    Rhodus NL, Bloomquist C, Liljemark W, Bereuter J. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjögren’s syndrome. J Otolaryngol. 1997;26:300–5.PubMedGoogle Scholar
  18. 18.
    Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, Alarcón-Segovia D, Kraus A. Oral candidiasis and Sjögren’s syndrome. J Rheumatol. 1998;25:911–5.PubMedGoogle Scholar
  19. 19.
    Yamamoto T, Yokoyama A, Yamamoto Y, Mamada A. Erythema nodosum associated with Sjögren’s syndrome. Br J Rheumatol. 1997;36:707–8.PubMedCrossRefGoogle Scholar
  20. 20.
    McGovern TW, Erickson AR, Fitzpatrick JE. Sjögren’s syndrome plasma cell panniculitis and hidradenitis. J Cutan Pathol. 1996;23:170–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Chandrupatla C, Xia L, Stratman EJ. Granulomatous panniculitis associated with Sjögren syndrome. Arch Dermatol. 2008;144:815–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Tait CP, Yu LL, Rohr J. Sjögren’s syndrome and granulomatous panniculitis. Australas J Dermatol. 2000;41:187–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Massone C, Kodama K, Salmhofer W, Abe R, Shimizu H, Parodi A, et al. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases. J Cutan Pathol. 2005;32:396–404.PubMedCrossRefGoogle Scholar
  24. 24.
    Hamadah IR, Banka N. Autosomal recessive plasma cell panniculitis with morphea-like clinical manifestation. J Am Acad Dermatol. 2006;54(5 Suppl):S189–91.PubMedCrossRefGoogle Scholar
  25. 25.
    Meijer JM, Schonland SO, Palladini G, Merlini G, Hegenbart U, Ciocca O, et al. Sjögren’s syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum. 2008;58:1992–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Yoneyama K, Tochigi N, Oikawa A, Shinkai H, Utani A. Primary localized cutaneous nodular amyloidosis in a patient with Sjögren’s syndrome: a review of the literature. J Dermatol. 2005;32(2):120–3.PubMedGoogle Scholar
  27. 27.
    Schwendiman MN, Beachkofsky TM, Wisco OJ, Owens NM, Hodson DS. Primary cutaneous nodular amyloidosis: case report and review of the literature. Cutis. 2009;84:87–92.PubMedGoogle Scholar
  28. 28.
    Konishi A, Fukuoka M, Nishimura Y. Primary localized cutaneous amyloidosis with unusual clinical features in a patient with Sjögren’s syndrome. J Dermatol. 2007;34:394–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Srivastava M. Primary cutaneous nodular amyloidosis in a patient with Sjögren’s syndrome. J Drugs Dermatol. 2006;5:279–80.PubMedGoogle Scholar
  30. 30.
    Kitajima Y, Seno J, Aoki S, Tada S, Yaoita H. Nodular primary cutaneous amyloidosis. Isolation and characterization of amyloid fibrils. Arch Dermatol. 1986;122:1425–30.PubMedCrossRefGoogle Scholar
  31. 31.
    Inazumi T, Hakuno M, Yamada H, Tanaka M, Naka W, Tajima S, et al. Characterization of the amyloid fibril from primary localized cutaneous nodular amyloidosis associated with Sjögren’s syndrome. Dermatology. 1994;189:125–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Aoki A, Ono S, Ueda A, Hagiwara E, Takashi T, Ideguchi H, et al. Two cases of limited cutaneous nodular amyloidosis with primary Sjögren’s syndrome. Nihon Rinsho Meneki Gakkai Kaishi. 2002;25:205–11.PubMedCrossRefGoogle Scholar
  33. 33.
    Richey TK, Bennion SD. Etiologies of the sicca syndrome: primary systemic amyloidosis and others. Int J Dermatol. 1996;35(8):553–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med. 1978;89:888–92.PubMedGoogle Scholar
  35. 35.
    Ekström Smedby K, Vajdic CM, Falster M, Engels EA, Martínez-Maza O, Turner J, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111:4029–38.PubMedCrossRefGoogle Scholar
  36. 36.
    Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165:2337–44.PubMedCrossRefGoogle Scholar
  37. 37.
    Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren’s syndrome. Arthritis Rheum. 2002;46:741–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Skopouli FN, Dafni U, Ioannidis JPA, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren’s syndrome. Semin Arthritis Rheum. 2000;29:296–304.PubMedCrossRefGoogle Scholar
  39. 39.
    Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren’s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren’s Syndrome. Arthritis Rheum. 1999;42:1765–72.PubMedCrossRefGoogle Scholar
  40. 40.
    Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore). 2009;88:284–93.CrossRefGoogle Scholar
  41. 41.
    Ramos-Casals M, Brito-Zerón P, Perez-DE-Lis M, Diaz-Lagares C, Bove A, Soto MJ, et al. Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjögren’s syndrome. J Rheumatol. 2010;37:585–90.PubMedCrossRefGoogle Scholar
  42. 42.
    Renic A, Nousari HC. Other rheumatologic diseases. In: Bolognia J, Jorizzo J, Rapini R, ­editors. Dermatology. Elsevier; Burlington, Massachusetts, USA 2003. p 636–8.Google Scholar
  43. 43.
    Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T, et al. Lymphomas in patients with Sjögren’s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood. 1997;90:766–75.PubMedGoogle Scholar
  44. 44.
    Quartuccio L, Fabris M, Salvin S, Maset M, De Marchi G, De Vita S. Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation. Int J Rheumatol. 2009;2009:424935.PubMedGoogle Scholar
  45. 45.
    Kristinsson SY, Koshiol J, Björkholm M, Goldin LR, McMaster ML, Turesson I, et al. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst. 2010;102(8):557–67.PubMedCrossRefGoogle Scholar
  46. 46.
    Yokota K, Akiyama Y, Adachi D, Shindo Y, Yoshida Y, Miyoshi F, et al. Subcutaneous panniculitis-like T-cell lymphoma accompanied by Sjögren’s syndrome. Scand J Rheumatol. 2009;38:494–5.PubMedCrossRefGoogle Scholar
  47. 47.
    Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol. 1979;115:1409–15.PubMedCrossRefGoogle Scholar
  48. 48.
    Sontheimer RD. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev. 2005;4:253–63.PubMedCrossRefGoogle Scholar
  49. 49.
    Sontheimer RD, Maddison PJ, Reichlin M, Jordan RE, Stastny P, Gilliam JN. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med. 1982;97:644–71.Google Scholar
  50. 50.
    Black DR, Hornung CA, Schneider PD, Callen JP. Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus. Arch Dermatol. 2002;138:1175–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  • Hobart W. Walling
    • 1
  • Richard D. Sontheimer
    • 2
  1. 1.Private Practice of DermatologyCoralvilleUSA
  2. 2.Department of DermatologyUniversity of Utah School of MedicineSalt Lake CityUSA

Personalised recommendations